# OnCo record cytarabine-7-3 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cytarabine-7-3/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cytarabine-7-3" ;
  schema:name "Cytarabine + anthracycline ('7+3')"@en ;
  schema:description "The intensive chemotherapy that has induced remission in fit AML patients since 1973: seven days of one drug, three of another. Still the backbone that targeted drugs are added to."@en ;
  schema:url <https://onco.cc/drugs/cytarabine-7-3/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cytarabine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q180983> ;
  schema:citation <https://en.wikipedia.org/wiki/Cytarabine> ;
  onco:status "standard-of-care" ;
  onco:modality "Cytotoxic regimen" ;
  onco:approval "US 1969: Cytarabine approved for acute leukaemia; 7+3 established 1973" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:trials <https://onco.cc/trials/ratify/>, <https://onco.cc/trials/quantum-first/>, <https://onco.cc/trials/alfa-0701/>, <https://onco.cc/trials/aaml0531/> .